Shalby enterprise value

Share price at each year-end

Tap a line for its trend	Currentlast 12M	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus


1,311	—	—	—	—	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
84.2	84.2	129	108	158
0.5	0.5	3.1	7.4	−0.1
540	540	427	314	181
1,767	—	—	—	—
455	455	297	206	22.5
₹164.36	—	—	—	—

1,545	1,545	1,422	1,322	1,108
34.9%	34.9%	30.0%	23.8%	16.3%
0.31×	—	—	—	—

1.50×	—	—	—	—
12.37×	—	—	—	—
25.03×	—	—	—	—
1,176	1,141	1,087	934	805
143	143	133	177	137
70.6	72.8	66.8	125	88.7
—	−0.0	−4.3	19.6	67.8
−149	−149	−75.8	−27.5	49.3
—	−164	−96.6	−32.0	46.8
—	149	71.4	47.1	18.5

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

SHALBY₹121.96

Shalby Limited

· Pharma & Health

₹ CrorePeersGKSL GPTHEALTH INDRAMEDCO ARTEMISMED LOTUSEYE DRAGARWQ KMCSHIL KOVAIMcap ₹1,311 Cr

HighlightsEnterprise Value Multiples Per ShareAnnuals · FY-end closes

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Current/LTM TTM · last close
Market Capitalization	—	—	—	—	1,311.3
- Cash, Equiv & ST Investments	158.0	107.8	129.4	84.2	84.2
+ Minority Interest	-0.1	7.4	3.1	0.5	0.5
+ Total Debt	180.5	314.0	426.7	539.6	539.6
Enterprise Value	—	—	—	—	1,767.2
Net Debt (memo)	22.5	206.1	297.3	455.5	455.5
EV per Share	—	—	—	—	164.36

Total Capital	1,108.1	1,321.7	1,422.0	1,545.3	1,545.3
Total Debt/Total Capital	16.29	23.75	30.01	34.92	34.92
Total Debt/EV	—	—	—	—	0.31

EV/Sales	—	—	—	—	1.50
EV/EBITDA	—	—	—	—	12.37
EV/EBIT	—	—	—	—	25.03
Reference Items — Trailing FY Values
Sales	804.9	933.7	1,087.0	1,141.4	1,176.2
EBITDA	136.7	177.0	132.6	142.8	142.8
EBIT	88.7	124.8	66.8	72.8	70.6
Operating Cash Flow	67.8	19.6	-4.3	-0.0	—
Free Cash Flow	49.3	-27.5	-75.8	-149.1	-149.1
FCFF (free cash flow to the firm)	46.8	-32.0	-96.6	-164.0	—
Capital Expenditure	18.5	47.1	71.4	149.0	—

Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.